Literature DB >> 9246290

Correction of blepharoconjunctivitis-related upper eyelid entropion using the anterior lamellar reposition technique.

M C Rhatigan1, J L Ashworth, K Goodall, B Leatherbarrow.   

Abstract

Upper eyelid entropion is a complication of chronic blepharoconjunctivitis which may be easily missed unless careful examination of the lid margin of patients with trichiasis is carried out. Many patients undergo years of unsuccessful treatment for trichiasis because the underlying upper eyelid entropion has not been detected. We would like to recommend the already established procedure of anterior lamellar repositioning as a more permanent solution to this distressing condition and present the results of this procedure on 19 consecutive patients (28 lids). Our surgical technique is described and the results in this group of patients reported. The procedure was successful in 24 of 28 eyelids (85%), with success being defined as complete resolution of symptoms for a follow-up period of at least 10 months. Anterior lamellar repositioning is easy and relatively quick to perform and provides good functional and cosmetic results.

Entities:  

Mesh:

Year:  1997        PMID: 9246290     DOI: 10.1038/eye.1997.24

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  3 in total

1.  Anterior lamellar recession for management of upper eyelid cicatricial entropion and associated eyelid abnormalities.

Authors:  Tamer I Gawdat; Mahmoud A Kamal; Ahmed S Saif; Mostafa M Diab
Journal:  Int J Ophthalmol       Date:  2017-12-18       Impact factor: 1.779

2.  Anterior lamellar recession, blepharoplasty, and supratarsal fixation for cicatricial upper eyelid entropion without lagophthalmos.

Authors:  G H Aghai; A Gordiz; K G Falavarjani; M B Kashkouli
Journal:  Eye (Lond)       Date:  2016-02-12       Impact factor: 3.775

3.  Upper eyelid levator-recession and anterior lamella repositioning through the grey-line: Avoiding a skin-crease incision.

Authors:  Nidhi Pandey; Anuradha Jayaprakasam; Ilan Feldman; Raman Malhotra
Journal:  Indian J Ophthalmol       Date:  2018-02       Impact factor: 1.848

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.